| __timestamp | ACADIA Pharmaceuticals Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 4534000000 |
| Thursday, January 1, 2015 | 73869000 | 5920000000 |
| Friday, January 1, 2016 | 99284000 | 4940000000 |
| Sunday, January 1, 2017 | 149189000 | 6411000000 |
| Monday, January 1, 2018 | 187163000 | 6345000000 |
| Tuesday, January 1, 2019 | 240385000 | 6148000000 |
| Wednesday, January 1, 2020 | 319130000 | 11143000000 |
| Friday, January 1, 2021 | 239415000 | 10195000000 |
| Saturday, January 1, 2022 | 361575000 | 9509000000 |
| Sunday, January 1, 2023 | 351619000 | 9299000000 |
| Monday, January 1, 2024 | 11159000000 |
Unleashing insights
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc. have demonstrated contrasting yet intriguing R&D investment strategies. From 2014 to 2023, Bristol-Myers Squibb consistently allocated substantial resources to R&D, peaking in 2020 with a remarkable 146% increase from 2014. This commitment underscores their dedication to pioneering treatments and maintaining a competitive edge.
Conversely, ACADIA Pharmaceuticals, while smaller in scale, exhibited a dynamic growth trajectory, with R&D expenses surging by nearly 480% over the same period. This aggressive investment reflects their ambition to expand their therapeutic portfolio. The data reveals a compelling narrative of how two industry players navigate the complex landscape of drug development, each carving a unique path to innovation.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending